Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

ZEAKON DIAGNOSTICS : revenue, balance sheet and financial ratios

ZEAKON DIAGNOSTICS is a French company founded 19 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in ETRELLES-ET-LA-MONTBLEUSE (70700), this company of category PME shows in 2018 a net income negative of -80 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ZEAKON DIAGNOSTICS (SIREN 494809270)
Indicator 2018
Revenue N/C
Net income -79 732 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2018, ZEAKON DIAGNOSTICS records a net loss of 80 k€. This deficit will reduce equity on the balance sheet.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-79 732 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

7.026%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

3.128%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.6%

Solvency indicators evolution
ZEAKON DIAGNOSTICS

Sector positioning

Debt ratio
7.03 2018
2018
Q1: 0.0
Med: 6.44
Q3: 48.65
Average

In 2018, the debt ratio of ZEAKON DIAGNOSTICS (7.03) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
3.13% 2018
2018
Q1: 14.72%
Med: 36.83%
Q3: 60.55%
Average

In 2018, the financial autonomy of ZEAKON DIAGNOSTICS (3.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 100.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

100.629

Liquidity indicators evolution
ZEAKON DIAGNOSTICS

Sector positioning

Liquidity ratio
100.63 2018
2018
Q1: 129.19
Med: 188.39
Q3: 314.35
Watch

In 2018, the liquidity ratio of ZEAKON DIAGNOSTICS (100.63) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of ZEAKON DIAGNOSTICS in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare ZEAKON DIAGNOSTICS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about ZEAKON DIAGNOSTICS

What is the revenue of ZEAKON DIAGNOSTICS ?

The revenue of ZEAKON DIAGNOSTICS is not publicly disclosed (confidential accounts filed with INPI).

Is ZEAKON DIAGNOSTICS profitable?

ZEAKON DIAGNOSTICS recorded a net loss in 2018.

Where is the headquarters of ZEAKON DIAGNOSTICS ?

The headquarters of ZEAKON DIAGNOSTICS is located in ETRELLES-ET-LA-MONTBLEUSE (70700), in the department Haute-Saone.

Where to find the tax return of ZEAKON DIAGNOSTICS ?

The tax return of ZEAKON DIAGNOSTICS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ZEAKON DIAGNOSTICS operate?

ZEAKON DIAGNOSTICS operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.